18 results with keyword: 'photodynamic therapy treatment choroidal neovascularization complicating central chorioretinopathy'
Indocyanine green angiography (ICGA) revealed subfoveal CNV with hyperfluorescence dye leakage in the right eye (Figure 2A), and multiple areas of choroidal vascular
N/A
Subfoveal choroidal thickness after photodynamic therapy in patients with acute idio- pathic central serous chorioretinopathy. Chronic central serous chorioretinopathy is
N/A
Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy. Subfoveal
N/A
Laser photocoagulation, photodynamic therapy, and intravitreal bevaci- zumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic
N/A
Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks:
N/A
Data from the Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) study showed that verteporfin therapy of subfoveal choroidal neovascularization (CNV)
N/A
Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: a
N/A
The Responsible Entity achieved less than 70% of required recovery from a Reportable Balancing Contingency Event during the .
N/A
BCVA: best corrected visual acuity; CCSCR: chronic central serous chorioretinopathy; CNV: choroidal neovascularization; CRT: central retinal thickness; CRTA: central retinal
N/A
The User is reminded that, by virtue of current legislation, ONLINE is not subject to a general obligation to monitor information provided by Users; nevertheless ONLINE may be
N/A
ASP: Automated static perimetry; BCVA: Best-corrected visual acuity; CFT: Central foveal thickness; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy;
N/A
The risk of dofetilide induced ventricular arrhythmia was assessed in three ways in clinical studies: 1) by description of the QT interval and its relation to the dose and
N/A
102 Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK: Choroidal vascular remodel- ling in central serous chorioretinopathy af- ter indocyanine green guided photodynamic therapy
N/A
Intravitreal bevacizumab alone versus combined verteporfin photodynamic therapy and intravitreal bevacizumab for choroidal neovascularization in age- related macular
N/A
AMD: Age-related macular degeneration; CNV: Choroidal neovascularization; CSCR: Central serous chorioretinopathy; DOR: Diagnostic odds ratio; FA: Fluorescein angiography;
N/A
AMD: age related macular degeneration; BCVA: best-corrected visual acuity; CNV: choroidal neovascularization; CSC: central serous chorioretinopathy; FA: fluorescent angiograph;
N/A
5.8 Monitored and predicted PM 2.5 concentrations and meteorological parameters under unstable atmospheric conditions immediately after a heavy rain with the
N/A